跳至主要内容
临床试验/NCT01489891
NCT01489891已完成4 期

Usefulness of Applying Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopies Performed Under Sedation With Propofol- a Randomized Controlled Trial

Hospital Universitario Infanta Cristina1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
120
试验地点
1
主要终点
Rate of Administration of Propofol 1% Required to Obtain Uniform Sedation During Endoscopy

研究概览

简要总结

The purpose of this study is to determine the efficacy of application of the anaesthesia topical pharyngeal with lidocaine in esophagogastroduodenoscopy under propofol´s sedation, in therms of dosage and side effect´s reduction overall.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient´s over 18 years old that received standard indication for sedated esophagogastroduodenoscopy (American Society of Gastrointestinal Endoscopy Guidelines) in our centre between the period of study.

排除标准

  • Patients under 18 years old
  • Unable to obtain inform´s consent
  • Emergency endoscopy
  • Pregnant women
  • Encephalopathy
  • Well known allergic reaction to propofol, amide-anaesthesics, soy or eggs
  • Methaemoglobinemia induced factor risks
  • No previous or unknown fasting

研究组 & 干预措施

Lidocaine group

Active Comparator

Blinded spraying 50 mg of pharyngeal topical lidocaine 180 seconds before sedated esophagogastroduodenoscopy (EGD)

干预措施: Lidocaine (Drug)

Placebo

Placebo Comparator

Excipients without lidocaine. The flavour taste is the same of active comparator ensuring the masking.

干预措施: Placebo (Drug)

结局指标

主要结局

Rate of Administration of Propofol 1% Required to Obtain Uniform Sedation During Endoscopy

时间窗: 8 months

The propofol will be administered by an expert anaesthetist in repeated bolus (10-20 mg each 30-60 seconds) after an initial induction dosage (0.5-0.6 mg/kg ASA (American Society of Anaesthesiologists) I-II or 0.25-0.35 mg/kg ASA III-IV) to obtain an uniform level of sedation (OAAS 3 and bispectral index (BIS) 70-80) and adequate perceived patient tolerance (no gag-reflex, cough, sudden movements).

次要结局

  • Percentage of Participants With Adverse Events in Both Groups(Participants will be followed for the duration of hospital stay, an expected average of 2 hours postprocedure)
  • Likert Four Elements Scale to Evaluate the Satisfaction of Endoscopist(8 months)
  • Likert Four Elements Scale to Evaluate the Satisfaction of Anaesthetist(8 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Felipe de la Morena Lopez MD

Gastroenterologist. Head of endoscopy

Hospital Universitario Infanta Cristina

研究点 (1)

Loading locations...

相似试验

Usefulness of Lidocaine as Topical Pharyngeal... | 临床试验